Searched for
EMCURE PHARMA SHARES TODAY
US stocks today: S&P 500, Nasdaq edge lower as tech shares slideUS stocks ended slightly lower as weakness in technology and semiconductor shares weighed on sentiment, even as Meta rose after reports of ...- Mankind Pharma partners Denovo Sciences for AI-led drug discoveryMankind Pharma has partnered with Denovo Sciences to accelerate drug discovery using artificial intelligence. This collaboration aims to si...
- Two Trades for Today: An auto sector major for a 6.25% upmove, a mid-cap pharma stock for a gain of almost 7%Our technical analysts identify select stocks every trading day that may gain momentum even in volatile markets. Here are the technical cal...
- Mankind Pharma joins hands with Denovo Sciences for AI-powered drug discoveryMankind Pharma has joined forces with Denovo Sciences to revolutionize drug discovery using artificial intelligence. This strategic partner...
- Why KPIT Tech shares crashed 17% today: The BMW & Volkswagen connection explainedKPIT Technologies witnessed a significant 17% stock plunge following a revenue slowdown warning for Q1FY27, primarily due to unexpected cut...
- Telangana plans drug discovery push to move Hyderabad up pharma value chainTelangana is charting a new course to elevate Hyderabad into a global drug discovery hub. The state is fostering an integrated ecosystem by...
- Cupid shares gain 2% as firm raises FY27 guidance, expects Q1 revenue to top Rs 150 croreCupid shares gained 2% as the company anticipates a record Q1 FY27 revenue exceeding Rs 150 crore. Buoyed by strong market visibility, Cupi...
- GIFT Nifty signals muted start for Dalal Street amid cautious tradeIndian markets experienced a volatile session ahead of monthly expiry, with the Nifty closing lower at 23,866. Geopolitical tensions in Wes...
- Dalal Street set for a positive start as GIFT Nifty trades higherIndian markets experienced a downturn on Monday, with the Nifty closing below 24,000 due to profit-taking and geopolitical concerns. IT and...
- Ahead of Market: 10 things that will decide stock market action on TuesdayIndian equities ended lower, snapping a two-day rally as escalating Iran-US tensions and profit booking weighed on sentiment. Sensex fell 3...
- 2 top stock recommendations from Vinay RajaniIndian equity markets are experiencing a cautious phase, consolidating within a defined range as fresh buying momentum remains elusive. Tec...
- Global Market Today: Asian shares slip, oil pares climbGlobal markets are showing cautious optimism as US and Iran reportedly step back from further conflict escalation, with talks scheduled in ...
- Stocks in news: Waaree Energies, Kotak Bank, HDFC Bank, Strides Pharma, Persistent SystemsIndian markets showed volatility, ending nearly flat despite positive signals. Analysts note Nifty faces resistance from key moving average...
- Ahead of Market: 10 things that will decide D-Street action on MondayIndian markets closed marginally higher on Thursday after a volatile expiry session, with the Sensex rising 109 points to 77,100.47 and the...
- For investors with ability – and patience to wait 3 years, not 3 months: 6 large-cap stocks with upside potential of up to 33%The interesting point about the large-cap space today is not that prices have collapsed. In most cases, they have not. The more important c...
- India's CDMO industry set for global shift as pharma diversifies beyond China: Sai Life SciencesIndian contract manufacturers are poised for significant growth as global pharmaceutical giants diversify away from China. Companies like S...
- Honasa Consumer to buy 58% stake in Fluence Pharma at Rs 135-crore enterprise valueMamaearth's parent company, Honasa Consumer, is acquiring a majority stake in nutraceuticals brand Fluence Pharma for ₹135 crore. This stra...
- Ahead of Market: 10 things that will decide stock market action on WednesdaySensex and Nifty plunged over 1% on Tuesday amid global market weakness, IT sector losses, a weaker rupee and fresh foreign fund outflows. ...
- Stocks in news: Emcure Pharma, Dixon Technologies, Ajanta Pharma, Godrej Properties, VedantaIndian markets experienced a volatile session, closing higher amidst mixed signals. Bulls are defending the 23,000 level in Nifty, but unce...
- PE investor BC Investments sells Rs 612 crore stake in Emcure Pharma; Kotak MF picks up stakePrivate equity firm BC Investments IV sold a Rs 612 crore stake in Emcure Pharmaceuticals to Kotak Mahindra Mutual Fund at Rs 1,700 per sha...
Load More
